Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells

Soo Kyung Lee, Jung Ok Lee, Ji Hae Kim, Su Jin Kim, Ga Young You, Ji Wook Moon, Jin Hee Jung, Sun-Hwa Park, Kyung Ok Uhm, Ji Man Park, Pann Ghill Suh, Hyeon Soo Kim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Insulin resistance is the primary cause responsible for type 2 diabetes. Phosphatase and tensin homolog (PTEN) plays a negative role in insulin signaling and its inhibition improves insulin sensitivity. Metformin is a widely used insulin-sensitizing drug; however, the mechanism by which metformin acts is poorly understood. To gain insight into the role of PTEN, we examined the effect of metformin on PTEN expression. Metformin suppressed the expression of PTEN in an AMP-activated protein kinase (AMPK)-dependent manner in preadipocyte 3T3-L1 cells. Knock-down of PTEN potentiated the increase in insulin-mediated phosphorylation of Akt/ERK. Metformin also increased the phosphorylation of c-Jun N-terminal kinase (JNK)-c-Jun and mammalian target of rapamycin (mTOR)-p70S6 kinase pathways. Both pharmacologic inhibition and knock-down of AMPK blocked metformin-induced phosphorylation of JNK and mTOR. Knock-down of AMPK recovered the metformin-induced PTEN down-regulation, suggesting the involvement of AMPK in PTEN regulation. PTEN promoter activity was suppressed by metformin and inhibition of mTOR and JNK by pharmacologic inhibitors blocked metformin-induced PTEN promoter activity suppression. These findings provide evidence for a novel role of AMPK on PTEN expression and thus suggest a possible mechanism by which metformin may contribute to its beneficial effects on insulin signaling.

Original languageEnglish
Pages (from-to)1259-1267
Number of pages9
JournalJournal of Cellular Biochemistry
Volume112
Issue number5
DOIs
Publication statusPublished - 2011 May 1

Fingerprint

3T3-L1 Cells
AMP-Activated Protein Kinases
Metformin
Phosphoric Monoester Hydrolases
Down-Regulation
Insulin
Phosphorylation
JNK Mitogen-Activated Protein Kinases
Sirolimus
Insulin Resistance
Tensins
Medical problems
Type 2 Diabetes Mellitus
Phosphotransferases

Keywords

  • adipocyte
  • AMPK
  • insulin
  • metformin
  • PTEN

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells. / Lee, Soo Kyung; Lee, Jung Ok; Kim, Ji Hae; Kim, Su Jin; You, Ga Young; Moon, Ji Wook; Jung, Jin Hee; Park, Sun-Hwa; Uhm, Kyung Ok; Park, Ji Man; Suh, Pann Ghill; Kim, Hyeon Soo.

In: Journal of Cellular Biochemistry, Vol. 112, No. 5, 01.05.2011, p. 1259-1267.

Research output: Contribution to journalArticle

Lee, SK, Lee, JO, Kim, JH, Kim, SJ, You, GY, Moon, JW, Jung, JH, Park, S-H, Uhm, KO, Park, JM, Suh, PG & Kim, HS 2011, 'Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells', Journal of Cellular Biochemistry, vol. 112, no. 5, pp. 1259-1267. https://doi.org/10.1002/jcb.23000
Lee, Soo Kyung ; Lee, Jung Ok ; Kim, Ji Hae ; Kim, Su Jin ; You, Ga Young ; Moon, Ji Wook ; Jung, Jin Hee ; Park, Sun-Hwa ; Uhm, Kyung Ok ; Park, Ji Man ; Suh, Pann Ghill ; Kim, Hyeon Soo. / Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells. In: Journal of Cellular Biochemistry. 2011 ; Vol. 112, No. 5. pp. 1259-1267.
@article{3f633ac67b634a199df2de16ea83319f,
title = "Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells",
abstract = "Insulin resistance is the primary cause responsible for type 2 diabetes. Phosphatase and tensin homolog (PTEN) plays a negative role in insulin signaling and its inhibition improves insulin sensitivity. Metformin is a widely used insulin-sensitizing drug; however, the mechanism by which metformin acts is poorly understood. To gain insight into the role of PTEN, we examined the effect of metformin on PTEN expression. Metformin suppressed the expression of PTEN in an AMP-activated protein kinase (AMPK)-dependent manner in preadipocyte 3T3-L1 cells. Knock-down of PTEN potentiated the increase in insulin-mediated phosphorylation of Akt/ERK. Metformin also increased the phosphorylation of c-Jun N-terminal kinase (JNK)-c-Jun and mammalian target of rapamycin (mTOR)-p70S6 kinase pathways. Both pharmacologic inhibition and knock-down of AMPK blocked metformin-induced phosphorylation of JNK and mTOR. Knock-down of AMPK recovered the metformin-induced PTEN down-regulation, suggesting the involvement of AMPK in PTEN regulation. PTEN promoter activity was suppressed by metformin and inhibition of mTOR and JNK by pharmacologic inhibitors blocked metformin-induced PTEN promoter activity suppression. These findings provide evidence for a novel role of AMPK on PTEN expression and thus suggest a possible mechanism by which metformin may contribute to its beneficial effects on insulin signaling.",
keywords = "adipocyte, AMPK, insulin, metformin, PTEN",
author = "Lee, {Soo Kyung} and Lee, {Jung Ok} and Kim, {Ji Hae} and Kim, {Su Jin} and You, {Ga Young} and Moon, {Ji Wook} and Jung, {Jin Hee} and Sun-Hwa Park and Uhm, {Kyung Ok} and Park, {Ji Man} and Suh, {Pann Ghill} and Kim, {Hyeon Soo}",
year = "2011",
month = "5",
day = "1",
doi = "10.1002/jcb.23000",
language = "English",
volume = "112",
pages = "1259--1267",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells

AU - Lee, Soo Kyung

AU - Lee, Jung Ok

AU - Kim, Ji Hae

AU - Kim, Su Jin

AU - You, Ga Young

AU - Moon, Ji Wook

AU - Jung, Jin Hee

AU - Park, Sun-Hwa

AU - Uhm, Kyung Ok

AU - Park, Ji Man

AU - Suh, Pann Ghill

AU - Kim, Hyeon Soo

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Insulin resistance is the primary cause responsible for type 2 diabetes. Phosphatase and tensin homolog (PTEN) plays a negative role in insulin signaling and its inhibition improves insulin sensitivity. Metformin is a widely used insulin-sensitizing drug; however, the mechanism by which metformin acts is poorly understood. To gain insight into the role of PTEN, we examined the effect of metformin on PTEN expression. Metformin suppressed the expression of PTEN in an AMP-activated protein kinase (AMPK)-dependent manner in preadipocyte 3T3-L1 cells. Knock-down of PTEN potentiated the increase in insulin-mediated phosphorylation of Akt/ERK. Metformin also increased the phosphorylation of c-Jun N-terminal kinase (JNK)-c-Jun and mammalian target of rapamycin (mTOR)-p70S6 kinase pathways. Both pharmacologic inhibition and knock-down of AMPK blocked metformin-induced phosphorylation of JNK and mTOR. Knock-down of AMPK recovered the metformin-induced PTEN down-regulation, suggesting the involvement of AMPK in PTEN regulation. PTEN promoter activity was suppressed by metformin and inhibition of mTOR and JNK by pharmacologic inhibitors blocked metformin-induced PTEN promoter activity suppression. These findings provide evidence for a novel role of AMPK on PTEN expression and thus suggest a possible mechanism by which metformin may contribute to its beneficial effects on insulin signaling.

AB - Insulin resistance is the primary cause responsible for type 2 diabetes. Phosphatase and tensin homolog (PTEN) plays a negative role in insulin signaling and its inhibition improves insulin sensitivity. Metformin is a widely used insulin-sensitizing drug; however, the mechanism by which metformin acts is poorly understood. To gain insight into the role of PTEN, we examined the effect of metformin on PTEN expression. Metformin suppressed the expression of PTEN in an AMP-activated protein kinase (AMPK)-dependent manner in preadipocyte 3T3-L1 cells. Knock-down of PTEN potentiated the increase in insulin-mediated phosphorylation of Akt/ERK. Metformin also increased the phosphorylation of c-Jun N-terminal kinase (JNK)-c-Jun and mammalian target of rapamycin (mTOR)-p70S6 kinase pathways. Both pharmacologic inhibition and knock-down of AMPK blocked metformin-induced phosphorylation of JNK and mTOR. Knock-down of AMPK recovered the metformin-induced PTEN down-regulation, suggesting the involvement of AMPK in PTEN regulation. PTEN promoter activity was suppressed by metformin and inhibition of mTOR and JNK by pharmacologic inhibitors blocked metformin-induced PTEN promoter activity suppression. These findings provide evidence for a novel role of AMPK on PTEN expression and thus suggest a possible mechanism by which metformin may contribute to its beneficial effects on insulin signaling.

KW - adipocyte

KW - AMPK

KW - insulin

KW - metformin

KW - PTEN

UR - http://www.scopus.com/inward/record.url?scp=79953691133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953691133&partnerID=8YFLogxK

U2 - 10.1002/jcb.23000

DO - 10.1002/jcb.23000

M3 - Article

VL - 112

SP - 1259

EP - 1267

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 5

ER -